RxDoctor Payments Data

Suzanne Chick

Family · Warren, MINPI 1730698531

Payments from drug & device makers

$5,315in general payments, 2019–2025

Across 177 payments — averaging $30.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inari Medical, Inc.$2K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$1K
  • Kestra Medical Technology Services, Inc.$444
  • Shockwave Medical, Inc$293
  • Boston Scientific$245
  • Chiesi USA, Inc.$225
  • plus $853 from 12 others

What the payments were for

  • Travel & lodging$3106%
  • Food & beverage$5,00594%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,315 in reported general payments places this provider in the 95th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor21$8,919
ClopidogrelClopidogrel Bisulfate77$1,103
Isosorbide Mononitrate ErIsosorbide Mononitrate34$407
Atorvastatin Calcium20$217
Rosuvastatin Calcium14$186
Cephalexin22$50

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBrilinta$95$8,91921 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,657 family providers in Michigan.

Other family in Warren

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →